Ying‐Chun Lo

685 total citations
36 papers, 226 citations indexed

About

Ying‐Chun Lo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ying‐Chun Lo has authored 36 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Ying‐Chun Lo's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Cancer Genomics and Diagnostics (5 papers). Ying‐Chun Lo is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Cancer Genomics and Diagnostics (5 papers). Ying‐Chun Lo collaborates with scholars based in United States, Canada and Switzerland. Ying‐Chun Lo's co-authors include Marcus A. Badgeley, Barbara Burtness, Jennifer M. Boland, Marie E. Robert, Xuchen Zhang, Patricia LoRusso, Pallavi Patil, Aaron S. Mansfield, Kim Blenman and Z. Ping Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ying‐Chun Lo

28 papers receiving 224 citations

Peers

Ying‐Chun Lo
Jens‐Carsten Rückert Germany
Jamal Carter United States
Erika Hissong United States
Ping Ai China
Yuequan Shi China
Haocan Song United States
Dezuo Dong China
Maria Antista Italy
Marta Sonia González Spain
Pierre‐Marie Morice France
Jens‐Carsten Rückert Germany
Ying‐Chun Lo
Citations per year, relative to Ying‐Chun Lo Ying‐Chun Lo (= 1×) peers Jens‐Carsten Rückert

Countries citing papers authored by Ying‐Chun Lo

Since Specialization
Citations

This map shows the geographic impact of Ying‐Chun Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Chun Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Chun Lo more than expected).

Fields of papers citing papers by Ying‐Chun Lo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐Chun Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Chun Lo. The network helps show where Ying‐Chun Lo may publish in the future.

Co-authorship network of co-authors of Ying‐Chun Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐Chun Lo. A scholar is included among the top collaborators of Ying‐Chun Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐Chun Lo. Ying‐Chun Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lo, Ying‐Chun, Susan Armstrong, & Jason C. Chang. (2025). What is new for 2026: Challenges & updates in pulmonary pathology. Human Pathology. 169. 106021–106021.
2.
3.
Archang, Maani M., Ying‐Chun Lo, Linda X. Yin, et al.. (2024). Torus palatinus osteonecrosis: A hitherto unreported complication of long-term Denosumab use. SHILAP Revista de lepidopterología. 20(1). 772–776.
4.
Naso, Julia, Sarah M. Jenkins, Anja C. Roden, et al.. (2024). Prognostic Immunohistochemistry for Ki-67 and OTP on Small Biopsies of Pulmonary Carcinoid Tumors. The American Journal of Surgical Pathology. 48(6). 742–750. 2 indexed citations
5.
6.
Dehner, Carina, Ying‐Chun Lo, Jorge Torres‐Mora, et al.. (2024). Acral Fibrochondromyxoid Tumor: A Clinicopathologic and Molecular Genetic Study of 37 Cases. Modern Pathology. 37(12). 100599–100599. 3 indexed citations
7.
Folpe, Andrew L., Daniel B. Graham, Jeremy Molligan, et al.. (2024). Extraaxial Poorly Differentiated Chordoma: Clinicopathologic and Molecular Genetic Characterization. Modern Pathology. 38(3). 100664–100664.
8.
Lo, Ying‐Chun, et al.. (2023). Integrating Molecular Sequencing Into the Pathological Diagnosis of Clinically Suspected Non–Small Cell Lung Carcinomas. Modern Pathology. 36(5). 100126–100126. 2 indexed citations
9.
Naso, Julia, Ying‐Chun Lo, & Lynette M. Sholl. (2023). Updates in pathology and molecular diagnostics to inform the evolving landscape of thoracic surgery and oncology. Journal of Surgical Oncology. 127(2). 244–257. 2 indexed citations
10.
Lo, Ying‐Chun, et al.. (2023). Raphal Cord Rupture. JACC Case Reports. 11. 101791–101791. 1 indexed citations
11.
Koo, Chi Wan & Ying‐Chun Lo. (2023). Good’s Syndrome: Thymoma with Acquired Immunodeficiency. American Journal of Respiratory and Critical Care Medicine. 208(3). 322–324. 2 indexed citations
12.
Farooq, Ayesha, et al.. (2023). Nuclear Protein in Testis (NUT) Carcinoma: A Comprehensive Immunohistochemical Analysis of 57 Cases With Consideration of Interpretation and Pitfall Recognition. Archives of Pathology & Laboratory Medicine. 148(8). 898–904. 5 indexed citations
13.
Dehner, Carina, Ying‐Chun Lo, Shefali Chopra, et al.. (2023). CSF1 expression in xanthogranulomatous epithelial tumor/keratin-positive giant cell-rich tumor. Human Pathology. 143. 1–4. 9 indexed citations
14.
Lo, Ying‐Chun, et al.. (2023). Subtype of SCLC Is an Intrinsic and Persistent Feature Through Systemic Treatment. JTO Clinical and Research Reports. 4(9). 100561–100561. 9 indexed citations
15.
Roden, Anja C., Jennifer M. Boland, Tucker F. Johnson, et al.. (2022). Late Complications of COVID-19. Archives of Pathology & Laboratory Medicine. 146(7). 791–804. 18 indexed citations
16.
Lo, Ying‐Chun, Rupa Narayan, Valentina Nardi, & Jochen K. Lennerz. (2021). Two In Cis Variants—Two Worlds Apart. The Oncologist. 26(12). 997–999. 1 indexed citations
17.
Lo, Ying‐Chun, Christina Price, Kim Blenman, et al.. (2020). Checkpoint Inhibitor Colitis Shows Drug-Specific Differences in Immune Cell Reaction That Overlap With Inflammatory Bowel Disease and Predict Response to Colitis Therapy. American Journal of Clinical Pathology. 156(2). 214–228. 15 indexed citations
18.
Sullivan, Mackenzie W., et al.. (2020). Superior Vena Cava Syndrome associated with recurrent uterine adenosarcoma. Gynecologic Oncology Reports. 33. 100613–100613. 2 indexed citations
19.
Lin, Z. Ping, Yong-Lian Zhu, Ying‐Chun Lo, et al.. (2018). Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer. PLoS ONE. 13(11). e0207399–e0207399. 28 indexed citations
20.
Lo, Ying‐Chun, et al.. (2017). Biomarker driven treatment of head and neck squamous cell cancer. PubMed. 2(1). 6–6. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens‐Carsten Rückert Breakdown of academic impact, for papers by Jamal Carter Breakdown of academic impact, for papers by Erika Hissong Breakdown of academic impact, for papers by Ping Ai Breakdown of academic impact, for papers by Yuequan Shi Breakdown of academic impact, for papers by Haocan Song Breakdown of academic impact, for papers by Dezuo Dong Breakdown of academic impact, for papers by Maria Antista Breakdown of academic impact, for papers by Marta Sonia González Breakdown of academic impact, for papers by Pierre‐Marie Morice
Rankless by CCL
2026